Considering LK101? A Clinical Assessment and Records Checklist
A useful LK101 enquiry starts with a clear medical history and a focused set of questions. Use this guide to organize the information for the clinical team and understand what an enquiry can—and cannot—decide.
Why eligibility needs an individual assessment
The manual discusses postoperative treatment and systemic treatment for selected adults with solid tumors, alone or alongside standard treatment. Cancer type, prior treatment, general health and sample suitability require assessment by the treating team.
Medical records to prepare
Prepare pathology reports, recent imaging, treatment and medication history, and available tumor-sample information for the clinical team. Obtain current collection and transport instructions from the hospital before arranging any sample shipment.
Group documents by date and identify the most recent pathology and imaging reports. Make a list of previous treatment names, treatment periods and current medicines. Ask the hospital what additional records or samples it needs before sending material. An initial enquiry is not a confirmed appointment or a decision to receive treatment.
Questions about risks and ongoing treatment
The manual lists injection-site reactions and flu-like symptoms, as well as potential serious reactions including systemic allergy and cytokine-release syndrome. Monitoring and management belong to the treating clinical team; discuss risks before deciding on treatment.
Confirm the receiving team and your next step
The supplied technical manual names West China Lecheng Hospital of Sichuan University (四川大学华西乐城医院), Hainan, as the treatment hospital. The team must confirm current access, eligibility and appointments for each enquiry.
Uwell helps coordinate enquiries and medical-record preparation. Eligibility and treatment decisions remain with the clinical team. Medical fees are quoted and collected directly by the provider; Uwell does not collect medical fees.
Sources and scope
Based on the supplied Likang introduction, technical manual and brochure. Manufacturer information is attributed and current access needs confirmation. These sources do not replace an individual clinical assessment.
Likang slides PDF 2–5, 7–20; technical manual printed pages 11–14.
ClinicalTrials.gov · NCT06054932
Source check: 10 October 2026. The NCT06054932 registry shows status UNKNOWN (last known RECRUITING; last update posted 26 September 2023). A separate lung-cancer study, NCT05886439, lists RECRUITING (last update posted 8 December 2025). These registry records do not confirm current availability or individual eligibility; ask the study or treating team.
This article was produced with AI assistance and reviewed against Uwell Cloud editorial and compliance standards.